Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Movano Inc. - Common Stock (NQ:MOVE)

13.77 +0.64 (+4.87%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Movano Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
12 Information Technology Stocks Moving In Friday's Intraday Session ↗
Gainers Marin Software (NASDAQ:MRIN) stock rose 42.59% to $21.5 during Friday's regular session. As of 12:30 EST, Marin Software's stock is trading at a volume of... 
Via Benzinga
News headline image
Movano Inc. Set to Join Russell Microcap Index
PLEASANTON, CA / ACCESSWIRE / June 8, 2021 / Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to help prevent and... 
From Movano Inc.
Via AccessWire
Topics Derivatives
News headline image
Movano Inc. Provides Business Update and Reports First Quarter 2021 Financial Results
Conference call begins at 2:00 p.m. Pacific time today PLEASANTON, CA / ACCESSWIRE / May 13, 2021 / Today, Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower... 
From Movano Inc.
Via AccessWire
News headline image
Movano Inc. to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
PLEASANTON, CA / ACCESSWIRE / April 21, 2021 / Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health to help prevent and better... 
From Movano Inc.
Via AccessWire
News headline image
Earnings Scheduled For May 13, 2021 ↗
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
Via Benzinga
News headline image
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight ↗
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a preference for risky bets at the expense of... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>